(Ĭleaning information: At least once a week, wash the actuator with warm water, shake off excess, and air dry thoroughly. PROAIR HFA inhaler should be discarded when the dose counter displays 0 or after the expiration date on the product, whichever comes first. Inhalation Aerosol: Each actuation delivers 108 mcg of albuterol sulfate from the actuator mouthpiece (equivalent to 90 mcg of albuterol base). Supplied in 8.5-g canister containing 200 actuations. Hypersensitivity to albuterol and any other PROAIR HFA Inhalation Aerosol Components.
Life-threatening paradoxical bronchospasm may occur. Discontinue PROAIR HFA immediately and treat with alternative therapy. Need for more doses of PROAIR HFA than usual may be a sign of deterioration of asthma and requires reevaluation of treatment. PROAIR HFA is not a substitute for corticosteroids. Use with caution in patients sensitive to sympathomimetic drugs and patients with cardiovascular or convulsive disorders. Immediate hypersensitivity reactions may occur. Hypokalemia and changes in blood glucose may occur.
To report SUSPECTED ADVERSE REACTIONS, contact Teva Respiratory, LLC at 1-88 or FDA at 1-80 or DRUG INTERACTIONS Most common adverse reactions (≥3.0% and >placebo) are headache, tachycardia, pain, dizziness, pharyngitis, and rhinitis. Other short-acting sympathomimetic aerosol bronchodilators and adrenergic drugs: May potentiate effect. (īeta-blockers: May decrease effectiveness of PROAIR HFA and produce severe bronchospasm. Patients with asthma should not normally be treated with beta-blockers. (ĭiuretics, or non-potassium sparing diuretics: May potentiate hypokalemia or ECG changes. (ĭigoxin: May decrease serum digoxin levels.
0 kommentar(er)
